Telix Pharmaceuticals Limited Stock Market Value
| TLPPF Stock | USD 17.24 0.24 1.41% |
| Symbol | Telix |
Telix Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Telix Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Telix Pharmaceuticals.
| 10/25/2024 |
| 01/23/2025 |
If you would invest 0.00 in Telix Pharmaceuticals on October 25, 2024 and sell it all today you would earn a total of 0.00 from holding Telix Pharmaceuticals Limited or generate 0.0% return on investment in Telix Pharmaceuticals over 90 days. Telix Pharmaceuticals is related to or competes with Genscript Biotech, Keros Therapeutics, Zentalis Pharmaceuticals, Innovent Biologics, MAIA Biotechnology, Nautilus Biotechnology, and Arcellx. Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation products for cance... More
Telix Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Telix Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Telix Pharmaceuticals Limited upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.84 | |||
| Information Ratio | 0.0912 | |||
| Maximum Drawdown | 13.39 | |||
| Value At Risk | (4.28) | |||
| Potential Upside | 5.54 |
Telix Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Telix Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Telix Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Telix Pharmaceuticals historical prices to predict the future Telix Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0939 | |||
| Jensen Alpha | 0.2945 | |||
| Total Risk Alpha | 0.2115 | |||
| Sortino Ratio | 0.0977 | |||
| Treynor Ratio | 0.9123 |
Telix Pharmaceuticals Backtested Returns
Telix Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Telix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Telix Pharmaceuticals Limited, which you can use to evaluate the volatility of the company. Please review Telix Pharmaceuticals' Risk Adjusted Performance of 0.0939, semi deviation of 2.36, and Coefficient Of Variation of 972.82 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Telix Pharmaceuticals holds a performance score of 8. The entity has a beta of 0.33, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Telix Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Telix Pharmaceuticals is expected to be smaller as well. Please check Telix Pharmaceuticals' maximum drawdown, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Telix Pharmaceuticals' existing price patterns will revert.
Auto-correlation | 0.31 |
Below average predictability
Telix Pharmaceuticals Limited has below average predictability. Overlapping area represents the amount of predictability between Telix Pharmaceuticals time series from 25th of October 2024 to 9th of December 2024 and 9th of December 2024 to 23rd of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Telix Pharmaceuticals price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Telix Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.54 |
Telix Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Telix Pharmaceuticals pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Telix Pharmaceuticals' pink sheet expected returns. We can calculate the autocorrelation of Telix Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Telix Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Telix Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Telix Pharmaceuticals pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Telix Pharmaceuticals pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Telix Pharmaceuticals pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Telix Pharmaceuticals Lagged Returns
When evaluating Telix Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Telix Pharmaceuticals pink sheet have on its future price. Telix Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Telix Pharmaceuticals autocorrelation shows the relationship between Telix Pharmaceuticals pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Telix Pharmaceuticals Limited.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Telix Pink Sheet
When determining whether Telix Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Telix Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Telix Pharmaceuticals Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Telix Pharmaceuticals Limited Stock:Check out Telix Pharmaceuticals Correlation, Telix Pharmaceuticals Volatility and Telix Pharmaceuticals Alpha and Beta module to complement your research on Telix Pharmaceuticals. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Telix Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.